Research Grade Briakinumab

Synonyms:

Interleukin-12 subunit beta, Il-12 subunit p40, NK cell stimulatory factor chain 2, NKSF2, Cytotoxic lymphocyte maturation factor 40 kDa subunit, CLMF p40, ABT-874, J695

Cat. No.:

DHD84002A pdf (datasheet)

Quantity/Size:

100 ug

Price:

$380.00 BUY

Concentration:

1.0 mg/ml, lot specific

Description:

Briakinumab (ABT-874) is a human monoclonal antibody being developed by Abbott Laboratories for the treatment of rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis. This the antibody targets the interleukins 12 and 23.

Uniprot Name:

Interleukin-12 subunit beta

Uniprot ID:

P29460

Purity:

> 95% as determined by SDS-PAGE

Specificity:

Human IL-12 subunit p40

Isotype:

IgG1-lambda

Formulation:

0.01M PBS, pH 7.4

Purification:

Protein A/G affinity chromatography

Storage/Stability:

Recommended storage, undiluted at 2-8°C for up to 1 week, or in working aliquots at -20°C to -80°C for up to 1 year. Avoid freeze/thaw cycles.